What amount sold does Klothea Bio, Inc. report in Form D filings?

The latest linked filings report $6.9M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Klothea Bio, Inc.'s most recent SEC filing?

Klothea Bio, Inc.'s most recent Form D filing was on 2026-09-08.

How many investors does Klothea Bio, Inc. have?

The most recent Form D filing lists 22 investor(s).

What type of securities does Klothea Bio, Inc. offer?

Klothea Bio, Inc.'s SEC Form D filings indicate debt offerings.

Klothea Bio, Inc.

CIK: 0002042705·Other Health Care·MIAMI, FL·Corporation·Founded 2024

Reported Sold

$6,885,000

Total Filings

Identified Offerings

Last Filed

Sep 8, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Sep 8, 2026Form D/A — Amendment

Reported sold: $6,885,000 · Target: $10,385,000

Rule 506(b)·22 investors

Changed: Reported amount sold, Reported investors, Sales commissions

May 28, 2026Form D/A — Amendment

Reported sold: $5,935,000 · Target: $10,385,000

Rule 506(b)·18 investors

Changed: Reported amount sold, Offering target, Reported investors, Reported revenue range

Feb 2, 2026Form D/A — Amendment

Reported sold: $2,935,000 · Target: $11,130,000

Rule 506(b)·11 investors

Changed: Reported amount sold, Reported investors, Reported revenue range

Oct 28, 2024Form D — New notice

Reported sold: $1,000,000 · Target: $11,130,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$12,500

Amendment Rate

75%

Latest reported sold across 1 identified offering

$6,885,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jeffrey B. Madden

Executive Officer, Director

Appears on 2 filings

Agustin Fernandez Santana III

Executive Officer, Director

Appears on 2 filings

Olivier Jarry

Executive Officer

Appears on 2 filings

Walter Schmidt

Director

Appears on 2 filings

Petr Sramek

Director

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 8, 2026	Amendment	$10,385,000	$6,885,000	22
May 28, 2026	Amendment	$10,385,000	$5,935,000	18
Feb 2, 2026	Amendment	$11,130,000	$2,935,000	11
Oct 28, 2024	New	$11,130,000	$1,000,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Prosper Health, Inc.

Other Health Care

Offering target: $10,029,002

Filed Sep 9, 2026